JANINE BULLMAN: Open Payments
NPI 1417443805 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,393 in 124 payments from 20 companies in 2025. Trend: 2023 $1,275 · 2024 $1,418 · 2025 $2,393
Food & beverage: $2,311Education: $82
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $593 |
| Ardelyx, Inc. | 19 | $434 |
| ABBVIE INC. | 21 | $342 |
| Phathom Pharmaceuticals, Inc. | 22 | $250 |
| PFIZER INC. | 8 | $141 |
| Gilead Sciences, Inc. | 2 | $101 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Madrigal Pharmaceuticals | 3 | $78 |
| Intercept Pharmaceuticals, Inc. | 3 | $57 |
| Ipsen Biopharmaceuticals, Inc | 2 | $50 |
Products named: TREMFYA, IBSRELA, VOQUEZNA, CREON, RINVOQ, VELSIPITY, DUPIXENT, REZDIFFRA.
Industry payments across SC — which companies pay providers there.
